Advanced search×

RGD targeting hyaluronic acid coating system for PEI-PBLG polycation gene carriers.

Huayu H Tian, Lin L Lin, Jie J Chen, Xuesi X Chen, Tae Gwan TG Park, and Atsushi A Maruyama

J Control Release 155(1):47-53 (2011) PMID 21281679

Hyaluronic acid (HA), a natural anionic mucopolysaccharide, was used to coat polyethylenimine-poly(γ-benzyl L-glutamate)/DNA (PEI-PBLG/DNA) complexes. HA was further modified by introducing RGD peptide with grafting density of one RGD in every 1.9 HA repeating units. HA can coat the cationic surface of PEI-PBLG/DNA complexes without destroying them even at high weight ratio of HA/PEI-PBLG/DNA=40/10/1. Coating the complexes by HA and HA-RGD caused lower surface charges and little bigger size than the naked PEI-PBLG/DNA. HA/PEI-PBLG/DNA has little lower transfection efficiency compared with naked PEI-PBLG/DNA, while the transfection efficiency of HA-RGD/PEI-PBLG/DNA is 9.7 times of HA/PEI-PBLG/DNA for the RGD target bonding affinity to the receptors on the cell surface. HA coating on PEI-PBLG/DNA reduced the electrostatic binding affinity to the cells while the RGD binding affinity for integrin on HeLa cells can not only compensate the reduced binding affinity but also enhance the affinity for HA-RGD/PEI-PBLG/DNA. RGD and RDG competition assay and lactate dehydrogenase (LDH) release studies further confirmed the specific target functions of RGD on HA. Cell viability measurements confirmed the high viability (above 70% viability) of the cells treated with HA-RGD and HA coated complex particles. These results would show that HA-RGD coated PEI-PBLG/DNA complexes have an attractive feature to a targeting in vivo non-viral gene delivery system.

Copyright © 2011 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.jconrel.2011.01.025
Version: za2963e q8zac q8zbe q8zc3 q8zdf q8ze4 q8zf0 q8zga

Similar articles you may find interesting…

  1. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
    Yuri Choi, Sang Eun Lee, ... Soo-Chan Kim

    J Dermatol 38(2):169-72 (2011) PMID 21269314

    We present a 67-year-old male MMP patient who had lesions on the oral and ocular mucous membranes and facial skin. By immunoblot analyses, immunoglobulin G autoantibodies in the patient's sera reacted with full-length BP180 and the 120-kDa ectodomain of BP180 (LAD-1). © 2010 Japanese Dermatological...
  2. Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy...
    Lippi G, Montagnana M, ... Franchini M

    Biomark Med 5(1):63-70 (2011) PMID 21319966

    The human glycoprotein (GP)IIb/IIIa belongs to a large family of cation-dependent adhesion molecules known as integrins, which share a common heterodimeric structure. The primary function of GPIIb/IIIa is to aid platelet aggregation by transmitting bidirectional signals across the pl...
  3. Lipoxin A4 Inhibits Porphyromonas gingivalis-Induced Aggregation and Reactive Oxygen Species Production by Modulating Neutrophil-Platelet In...
    E Borgeson, J Lonn, ... T Bengtsson

    Infect Immun 79(4):1489-1497 (2011) PMID 21263017

    We found that LXA4 significantly inhibits P. gingivalis-induced aggregation and ROS generation in whole blood. However, in platelet-depleted blood and in isolated neutrophils and platelets, respectively, LXA4 was unable to inhibit either aggregation or ROS production. In conclusion, this study sugge...